7351 Kirkwood Lane North
Suite 138
Maple Grove
MN
55369
763-445-2352.
info@lutonix.com
Product Categories
Related Content
In 2015, the FDA approved the first two drug-coated balloons for the U.S. market to treat peripheral artery disease in ...
April 02, 2015
May 23, 2014 — The first drug-eluting balloon to go up for review by the U.S. Food and Drug Administration (FDA) will be ...
May 23, 2014
January 25, 2012 — Physicians at University Hospitals (UH) Case Medical Center enrolled their first patient in LEVANT 2 ...
January 25, 2012
January 6, 2012 - C. R. Bard recently announced it acquired drug-eluting balloon maker Lutonix Inc. for $225 million ...
January 06, 2012
July 26, 2011 – The first patient has been enrolled in the LEVANT 2 clinical trial, a global, multi-center, randomized ...
July 26, 2011